Supriya Lifescience Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 37.75% vs -21.20% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 44.96% vs -30.94% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 40.50% vs -23.50% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -17.65% vs 21.43% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Supriya Lifesci. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

199.83

417.29

-217.46

-52.11%

Other Operating Income

0.00

Total Operating income

199.83

417.29

-217.46

-52.11%

Raw Material Cost

60.68

204.45

-143.77

-70.32%

Purchase of Finished goods

0.00

20.41

-20.41

-100.00%

(Increase) / Decrease In Stocks

-4.95

-14.86

9.91

66.69%

Employee Cost

24.48

43.12

-18.64

-43.23%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

46.98

90.18

-43.20

-47.90%

Total Expenditure (Excl Depreciation)

127.19

343.30

-216.11

-62.95%

Operating Profit (PBDIT) excl Other Income

72.64

73.99

-1.35

-1.82%

Other Income

2.73

3.15

-0.42

-13.33%

Operating Profit (PBDIT)

75.37

77.14

-1.77

-2.29%

Interest

0.42

10.66

-10.24

-96.06%

Exceptional Items

0.00

Gross Profit (PBDT)

74.95

66.48

8.47

12.74%

Depreciation

6.64

24.77

-18.13

-73.19%

Profit Before Tax

68.32

41.70

26.62

63.84%

Tax

17.89

10.77

7.12

66.11%

Provisions and contingencies

0.00

Profit After Tax

50.43

30.93

19.50

63.05%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

50.43

30.93

19.50

63.05%

Equity Capital

16.10

45.32

-29.22

-64.47%

Face Value

2.00

5.00

0.00

Reserves

0.00

Earnings per share (EPS)

6.26

3.41

2.85

83.58%

Diluted Earnings per share

6.27

3.41

2.86

83.87%

Operating Profit Margin (Excl OI)

36.35%

17.73%

0.00

18.62%

Gross Profit Margin

37.51%

15.93%

0.00

21.58%

PAT Margin

25.24%

7.41%

0.00

17.83%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 199.83 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 37.75% vs -21.20% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 20.31% vs 18.56% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 50.43 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 44.96% vs -30.94% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 9.27% vs 93.26% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 72.64 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 40.50% vs -23.50% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 12.25% vs 103.75% in Sep 2024

Quarterly - Interest

Interest 0.42 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -17.65% vs 21.43% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -2.33% vs -6.52% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 36.35%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024